NovaBay Pharmaceuticals Inc (AMEX:NBY)
$ 0.7051 0.0109 (1.57%) Market Cap: 3.45 Mil Enterprise Value: 4.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q4 2019 NovaBay Pharmaceuticals Inc Earnings Call Transcript

Mar 26, 2020 / 08:30PM GMT
Release Date Price: $1065.75 (-0.79%)
Operator

Welcome to the NovaBay Pharmaceuticals 2018 (sic - "2019") fourth-quarter and full-year's earning conference call. (Operator Instructions) As a reminder, this conference is being recorded Thursday, March 26, 2020.

I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain
LHA Investor Relations - IR

This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay Pharmaceuticals are Justin Hall, President, and Chief Executive Officer; and Jason Raleigh, the company's Chief Financial Officer.

I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of Federal Securities Laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results.

For a list and description of those risks and uncertainties, please review NovaBay's filings with the Securities and Exchange Commission at sec.gov. Furthermore, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot